The mutation of tumor suppressor gene TP53 rarely occurs in differentiated PTC and FTC while it is frequently reported in ATC (70%)54,55, positing that ATC can also arise from a BRAF-mutated PTC following a further acquisition in TP53 mutations. Here, BRAF is linked to thyroid cancer, nonmedullary, 2.